Akili Interactive, a prescription digital medicine company developing treatments for cognitive dysfunction, closed a $55 million Series C financing round led by Temasek. Other participating institutional and strategic investors included Baillie Gifford, Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), JAZZ